Genomic regulatory sequences in the pathogenesis of bipolar disorder
- PMID: 36824672
- PMCID: PMC9941178
- DOI: 10.3389/fpsyt.2023.1115924
Genomic regulatory sequences in the pathogenesis of bipolar disorder
Abstract
The lifetime prevalence of bipolar disorder is estimated to be about 2%. Epigenetics defines regulatory mechanisms that determine relatively stable patterns of gene expression by controlling all key steps, from DNA to messenger RNA to protein. This Mini Review highlights recent discoveries of modified epigenetic control resulting from genetic variants associated with bipolar disorder in genome-wide association studies. The revealed epigenetic abnormalities implicate gene transcription and post-transcriptional regulation. In the light of these discoveries, the Mini Review focuses on the genes PACS1, MCHR1, DCLK3, HAPLN4, LMAN2L, TMEM258, GNL3, LRRC57, CACNA1C, CACNA1D, and NOVA2 and their potential biological role in the pathogenesis of bipolar disorder. Molecular mechanisms under control of these genes do not translate into a unified picture and substantially more research is needed to fill the gaps in knowledge and to solve current limitations in prognosis and treatment of bipolar disorder. In conclusion, the genetic and functional studies confirm the complex nature of bipolar disorder and indicate future research directions to explore possible targeted treatment options, eventually working toward a personalized approach.
Keywords: RNA; bipolar disorder; epigenetics; functional genetic variant; genome-wide association study (GWAS); transcription.
Copyright © 2023 Levchenko and Plotnikova.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism.Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:157-62. doi: 10.1016/j.pnpbp.2014.05.017. Epub 2014 Jun 8. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24914473
-
Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings.Mol Psychiatry. 2022 Jul;27(7):2927-2939. doi: 10.1038/s41380-022-01523-9. Epub 2022 Mar 29. Mol Psychiatry. 2022. PMID: 35351989 Review.
-
Epigenetic Element-Based Transcriptome-Wide Association Study Identifies Novel Genes for Bipolar Disorder.Schizophr Bull. 2021 Oct 21;47(6):1642-1652. doi: 10.1093/schbul/sbab023. Schizophr Bull. 2021. PMID: 33772305 Free PMC article.
-
Genetics of bipolar disorder.Lancet. 2013 May 11;381(9878):1654-62. doi: 10.1016/S0140-6736(13)60855-7. Lancet. 2013. PMID: 23663951 Review.
-
A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.Pharmacogenomics. 2015;16(14):1547-63. doi: 10.2217/pgs.15.106. Epub 2015 Sep 7. Pharmacogenomics. 2015. PMID: 26343379
Cited by
-
Genetics, epigenetics, and neurobiology of childhood-onset depression: an umbrella review.Mol Psychiatry. 2024 Mar;29(3):553-565. doi: 10.1038/s41380-023-02347-x. Epub 2023 Dec 15. Mol Psychiatry. 2024. PMID: 38102485
-
Integrating single-cell with transcriptome-proteome Mendelian randomization reveals colorectal cancer targets.Discov Oncol. 2025 May 17;16(1):794. doi: 10.1007/s12672-025-02636-7. Discov Oncol. 2025. PMID: 40381082 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous